Global pharmaceutical filtration market to hit $21.75b by 2030
Regionally, North America was the largest pharmaceutical filtration market in 2024.
The global pharmaceutical filtration market is expected to grow from $14.35b in 2025 to $21.75b by 2030, representing a compound annual growth rate of 8.7%, according to a report by MarketsandMarkets.
The research firm said demand is being driven by the faster adoption of single-use filtration systems and assemblies, alongside rising requirements for sterile, high-concentration drug products.
Increased use of automated, closed manufacturing systems with real-time contamination control is also supporting market growth.
By product type, consumables are projected to dominate the market, accounting for about 84.1% of total revenue, reflecting recurring demand for filters, membranes, and related disposable components.
In terms of technology, microfiltration held the largest share of the market in 2024 and is expected to be the fastest-growing filtration technique through 2030, supported by its widespread use across multiple pharmaceutical and biopharmaceutical processes.
On the application side, final product processing is identified as the fastest-growing segment. This includes filtration steps used in API manufacturing, protein purification, vaccine and antibody production, filling operations, and viral clearance.
Regionally, North America was the largest pharmaceutical filtration market in 2024, whilst the Asia Pacific, which accounted for approximately 24.2% of global revenue, is expected to record the fastest growth.
MarketsandMarkets attributed this to expanding biopharmaceutical manufacturing capacity in the region and a stronger emphasis on GMP compliance and regulatory standards.
The report also highlighted enabling technologies, including advances in sterilising-grade membranes, AI-enabled process monitoring, high-throughput viral filtration, nanofiber membranes, and sustainability-oriented filter designs.
Key companies operating in the pharmaceutical filtration space include Danaher, Merck KGaA, Sartorius, 3M, Repligen, Thermo Fisher Scientific, Parker Hannifin, Eaton, Donaldson, Porvair, Alfa Laval, Corning, MANN+HUMMEL, Saint-Gobain, and STERIS, according to MarketsandMarkets.